spineart
-
Financial
Spineart Secures more than CHF20 Million in Convertible Financing Following Completion of BAGUERA®C IDE Studies Enrollment
GENEVA, March 18, 2024 /PRNewswire/ — Spineart, a global spine specialist working with surgeons to accelerate the adoption of cutting-edge technologies, has…
Read More » -
Spine
Spineart Completes Enrollment in the BAGUERA® IDE Trial for Two-Level Cervical Disc Replacement
GENEVA, March 8, 2024 /PRNewswire/ — Spineart SA, manufacturer of the BAGUERA®C Cervical Disc Prosthesis, today announced it has completed enrollment in…
Read More » -
Spine
Spineart Completes Enrollment In The BAGUERA®C IDE Trial For Single-Level Cervical Disc Replacement
GENEVA, Feb. 29, 2024 /PRNewswire/ — Spineart SA, manufacturer of the BAGUERA®C Cervical Disc Prosthesis, is delighted to announce completion of enrollment…
Read More » -
Robotics
Spineart and Ecential Robotics Announce a Partnership to Co-Develop Spine Surgery Applications and Co-Market the eCential Robotics’ Open Robotic Surgery Platform
PLAN-LES-OUATES (GENEVA), Switzerland and GIÈRES (GRENOBLE), France, Dec. 19, 2022 /PRNewswire/ — Spineart, a leading provider of spine surgery implants and eCential Robotics, a growth MedTech company that designs and produces an open system unifying robotics, surgical…
Read More » -
Spine
Spineart-100 U.S. Patients Treated In The Single Level IDE Clinical Trial Of BAGUERA®C Cervical Disc Prosthesis
LAGUNA HILLS, Calif., April 21, 2022 /PRNewswire/ — Spineart USA Inc. announced today that surgery has been performed on 100 patients in the single-level U.S.…
Read More » -
Spine
100th U.S. Patient Treated In IDE Clinical Trials Of Baguera® C Cervical Disc Prosthesis
LAGUNA HILLS, Calif., Nov. 16, 2021 /PRNewswire/ — Spineart USA Inc. announced today that the 100th surgery has been performed in their combined single-level and…
Read More » -
Biologics
Spineart reaches definitive agreement to acquire Meditech Spine LLC.
Spineart, a global spine player with headquarters in Geneva, Switzerland and US operations in Laguna Hills, California, has agreed to…
Read More » -
Spine
Cervical Posterior: Smart Solutions for Complex Surgeries
With an estimated market value of $350M, posterior cervical fusion is still an attractive growing market. Common indications for Posterior…
Read More » -
Financial
Gimv provides EUR 30 million of growth equity to fast-growing medical device company Spineart
20-09-2016 Spineart today announces that it secured a EUR 30 million investment from Gimv[1], which thus becomes an important shareholder…
Read More » -
Spine
SPINEART RECEIVES CLEARANCE FROM THE FDA TO MARKET ITS TI-LIFE TECHNOLOGY 3D TITANIUM INTERBODY DEVICES
Spineart is pleased to announce that it has received 510(k) clearance from the FDA to market its new JULIET®Ti lumbar interbody systems…
Read More » -
Spine
SPINEART LAUNCHES NEW TI-LIFE TECHNOLOGY 3D TITANIUM INTERBODY DEVICES
13 JULY 2016 Spineart is pleased to announce that it has received CE marking for its new JULIET®Ti lumbar interbody systems. The…
Read More » -
Spine
SPINEART ANNOUNCES PUBLICATION OF CLINICAL DATA FOR ITS BAGUERA®C ARTIFICAL CERVICAL DISC PROSTHESIS
5 JULY 2016 Spineart announced today the results published in the Journal of Spine from a multicenter European prospective…
Read More » -
Financial
Spineart USA First Quarter 2016
June 28, 2016 Activity Our revenues in the US grew 44% in the first quarter of 2016 compared to…
Read More » -
Top Stories
Spineart Announces Successful completion of 15,000th Implantation of Baguera C Artificial Cervical Disc
13 JUNE 2016 Spineart is pleased to announce that, as of the 1st of June 2016, more than 15’000…
Read More » -
Spine
Why You Need a UDI-Ready Line… or Even Better, a Sterile-Packed One
Written by: Jérôme Trividic UDI, the FDA Unique Device Identification System was signed into law back in 2007. Yet, eight years…
Read More »